Key Takeaways From Gritstone Bio Analyst Ratings
Key Takeaways From Gritstone Bio Analyst Ratings
Gritstone Bio分析師評級要點
The analysis of...Across the recent three months, 4 analysts have shared their insights on Gritstone Bio (NASDAQ:GRTS), expressing a variety of opinions spanning from bullish to bearish.
在最近的三個月裏，4位分析師就納斯達克上的Gritstone Bio（納斯達克：GRTS）發表了他們的見解，從看好到看淡等各種不同觀點。
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
以下表格概括了他們最近的評級，展示了過去30天內的情緒演變並與之前的幾個月進行了比較。
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $3.38, a high estimate of $5.00, and a low estimate of $0.50. Observing a downward trend, the current average is 20.47% lower than the prior average price target of $4.25.
分析師通過對12個月價格目標的評估提供了更深入的見解，顯示出平均目標爲$3.38，最高估值爲$5.00，最低估值爲$0.50。觀察到一種下降趨勢，當前的平均目標比之前的$4.25的平均價格目標低了20.47%。
Decoding Analyst Ratings: A Detailed Look
分析師評級解讀：詳細解析
The analysis of...
對最近...
登入免費觀看全文
登入/註冊
熱門討論
美聯儲暫停降息，你如何調整持倉？
美聯儲宣布基準利率維持在4.25%—4.50%不變，符合市場預期。你會如何配置資產？
Moo Live
01/30 03:25
FOMC新聞發佈會，2025年1月29日